Skip to main content

“haeday:)” aims to raise global awareness to ensure each and every patient receives faster diagnosis and the care they need to lead a healthy life. 
 

Dr Sijmen de Vries, Pharming’s CEO

- “We are proud to provide the first and only recombinant (C1- esterase inhibitor) protein replacement therapy for the treatment of acute angioedema attacks in adults and adolescents with HAE."
Cookies: This website uses cookies Check the cookies page for more information Accept Decline